rs34588967

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 3P and 20B. PM5PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_007055.4(POLR3A):​c.1745G>T​(p.Arg582Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0143 in 1,614,044 control chromosomes in the GnomAD database, including 190 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R582H) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0097 ( 14 hom., cov: 32)
Exomes 𝑓: 0.015 ( 176 hom. )

Consequence

POLR3A
NM_007055.4 missense

Scores

7
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.49
Variant links:
Genes affected
POLR3A (HGNC:30074): (RNA polymerase III subunit A) The protein encoded by this gene is the catalytic component of RNA polymerase III, which synthesizes small RNAs. The encoded protein also acts as a sensor to detect foreign DNA and trigger an innate immune response. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr10-78009889-C-T is described in Lovd as [Likely_pathogenic].
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), POLR3A. . Gene score misZ 2.3065 (greater than the threshold 3.09). Trascript score misZ 3.6654 (greater than threshold 3.09). GenCC has associacion of gene with leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome, Wiedemann-Rautenstrauch syndrome, hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome, tremor-ataxia-central hypomyelination syndrome, hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome, odontoleukodystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0123824775).
BP6
Variant 10-78009889-C-A is Benign according to our data. Variant chr10-78009889-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 130000.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00966 (1470/152188) while in subpopulation NFE AF= 0.0156 (1058/68018). AF 95% confidence interval is 0.0148. There are 14 homozygotes in gnomad4. There are 696 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POLR3ANM_007055.4 linkuse as main transcriptc.1745G>T p.Arg582Leu missense_variant 13/31 ENST00000372371.8 NP_008986.2 O14802

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POLR3AENST00000372371.8 linkuse as main transcriptc.1745G>T p.Arg582Leu missense_variant 13/311 NM_007055.4 ENSP00000361446.3 O14802

Frequencies

GnomAD3 genomes
AF:
0.00967
AC:
1470
AN:
152070
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00280
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0123
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0156
Gnomad OTH
AF:
0.00814
GnomAD3 exomes
AF:
0.00858
AC:
2158
AN:
251472
Hom.:
9
AF XY:
0.00840
AC XY:
1142
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.00338
Gnomad AMR exome
AF:
0.00700
Gnomad ASJ exome
AF:
0.0152
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000523
Gnomad FIN exome
AF:
0.00189
Gnomad NFE exome
AF:
0.0140
Gnomad OTH exome
AF:
0.00961
GnomAD4 exome
AF:
0.0147
AC:
21562
AN:
1461856
Hom.:
176
Cov.:
32
AF XY:
0.0142
AC XY:
10342
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.00254
Gnomad4 AMR exome
AF:
0.00686
Gnomad4 ASJ exome
AF:
0.0168
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.000800
Gnomad4 FIN exome
AF:
0.00251
Gnomad4 NFE exome
AF:
0.0177
Gnomad4 OTH exome
AF:
0.0140
GnomAD4 genome
AF:
0.00966
AC:
1470
AN:
152188
Hom.:
14
Cov.:
32
AF XY:
0.00935
AC XY:
696
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.00279
Gnomad4 AMR
AF:
0.0123
Gnomad4 ASJ
AF:
0.0164
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00245
Gnomad4 NFE
AF:
0.0156
Gnomad4 OTH
AF:
0.00806
Alfa
AF:
0.0106
Hom.:
15
Bravo
AF:
0.00986
TwinsUK
AF:
0.0194
AC:
72
ALSPAC
AF:
0.0218
AC:
84
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.0165
AC:
142
ExAC
AF:
0.00785
AC:
953
EpiCase
AF:
0.0156
EpiControl
AF:
0.0143

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024POLR3A: PM5, BP4, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxMay 10, 2021- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Leukoencephalopathy, ataxia, hypodontia, hypomyelination syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Neonatal pseudo-hydrocephalic progeroid syndrome;C4706676:Leukoencephalopathy, ataxia, hypodontia, hypomyelination syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsDec 17, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.54
D
Eigen
Benign
-0.20
Eigen_PC
Benign
-0.035
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.57
N
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-2.7
D
REVEL
Benign
0.14
Sift
Uncertain
0.0070
D
Sift4G
Uncertain
0.013
D
Polyphen
0.15
B
Vest4
0.60
MVP
0.79
MPC
0.47
ClinPred
0.029
T
GERP RS
3.9
Varity_R
0.16
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34588967; hg19: chr10-79769647; COSMIC: COSV99071299; COSMIC: COSV99071299; API